[go: up one dir, main page]

AU2001269708A1 - Novel method of use of multidrug resistance modulators - Google Patents

Novel method of use of multidrug resistance modulators

Info

Publication number
AU2001269708A1
AU2001269708A1 AU2001269708A AU6970801A AU2001269708A1 AU 2001269708 A1 AU2001269708 A1 AU 2001269708A1 AU 2001269708 A AU2001269708 A AU 2001269708A AU 6970801 A AU6970801 A AU 6970801A AU 2001269708 A1 AU2001269708 A1 AU 2001269708A1
Authority
AU
Australia
Prior art keywords
novel method
multidrug resistance
resistance modulators
modulators
multidrug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001269708A
Inventor
Anne Hollins Dantzig
Kevin Lynn Law
James Jacob Starling
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU2001269708A1 publication Critical patent/AU2001269708A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2001269708A 2000-07-18 2001-07-05 Novel method of use of multidrug resistance modulators Abandoned AU2001269708A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21922200P 2000-07-18 2000-07-18
US60/219,222 2000-07-18
PCT/US2001/016516 WO2002005818A2 (en) 2000-07-18 2001-07-05 Novel method of use of multidrug resistance modulators

Publications (1)

Publication Number Publication Date
AU2001269708A1 true AU2001269708A1 (en) 2002-01-30

Family

ID=22818379

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001269708A Abandoned AU2001269708A1 (en) 2000-07-18 2001-07-05 Novel method of use of multidrug resistance modulators

Country Status (2)

Country Link
AU (1) AU2001269708A1 (en)
WO (1) WO2002005818A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007008490A2 (en) * 2005-07-06 2007-01-18 Kanisa Pharmaceuticals, Inc. Zosuquidar, daunorubicin, and cytarabine for the treatment of cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643909A (en) * 1993-04-19 1997-07-01 Syntex (U.S.A.) Inc. 10,11-Methanodibenzosuberane derivatives
AU3486297A (en) * 1996-06-17 1998-01-07 Eli Lilly And Company Drug resistance and multidrug resistance modulators
CA2272390A1 (en) * 1996-11-22 1998-05-28 Julian Stanley Kroin Drug resistance and multidrug resistance modulators
GB9721352D0 (en) * 1997-10-08 1997-12-10 Medinnova Sf Resistance modifying agent
TWI267511B (en) * 1999-06-03 2006-12-01 Lilly Co Eli Process for preparing 10,11-methanobenzosuberane derivatives

Also Published As

Publication number Publication date
WO2002005818A2 (en) 2002-01-24
WO2002005818A3 (en) 2003-01-16

Similar Documents

Publication Publication Date Title
AU2001271559A1 (en) Drillable bridge plug
AU2001280599A1 (en) Compounds and methods
AUPQ998100A0 (en) Application development
AU2001253418A1 (en) Compounds and methods
AU2002210881A1 (en) Transdermal method
AU2001291019A1 (en) Method of modulating neovascularization
AU2000276782A1 (en) Spray-spin coating method
AU2001243394A1 (en) Compounds and methods
AU2001268701A1 (en) Methods of enhancing adhesion
AUPQ872300A0 (en) Compounds and methods
AU2001266176A1 (en) Methods
AU2001278951A1 (en) Compounds and methods
AU2002246912A1 (en) Receptor-binding compounds and methods for identifying them
AU2001237530A1 (en) Method
AU2000274825A1 (en) Cosmetic method
AU2002235277A1 (en) Compounds and methods
AU2001241636A1 (en) Halotherapy method
AU2001269708A1 (en) Novel method of use of multidrug resistance modulators
AU2001232104A1 (en) Method of determining viscosity
AU2001250536A1 (en) Methods
AU2994100A (en) Linked Bridge
AU2000273752A1 (en) Cosmetic method
AU2002221222A1 (en) Novel method and use
AU2002223274A1 (en) Method of marking an optical element
AU2001235770A1 (en) Method